BioSpace News Archive

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced financial results for the first quarter 2019

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, and Strata Oncology, Inc. (“Strata”), a precision oncology company, today announced that the companies have entered into a clinical development collaboration utilizing Strata’s precision drug development platform and proprietary biomarkers to evaluate AB122, Arcus’s clinical-stage anti-PD-1 antibody

CROP Infrastructure Corp. announced that its first Oklahoma farm’s tenant, Hempire Oklahoma has been issued Medical Cannabis Cultivation and processing licenses at its 1 acre location in Purcell, Oklahoma where the company will focus on high grade flower and extraction.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced that the Company will host a conference call on Thursday, May 9, 2019

More than 175 Advocates Take Action Together in the Nation’s Capital to END EPILEPSY®

Alliance for Better Health senior leader will help group develop a standardized terminology set for expansion of ICD-10 Z codes

84 percent of “attachments” sharing medical information between providers and health plans are exchanged through mail or fax, resulting in administrative inefficiency and delays in patient care

Incyte Corporation announced that it will present at the following investor conferences during the month of May

Health IT leader to demonstrate orthopedic EMR, Practice Management, Analytics capabilities and more at AAOE

Savara Inc. announced that the Company will report first quarter 2019 financial results and provide a business update on Thursday, May 9, 2019.